Aelis Farma SA

11/15/2026 | Press release | Distributed by Public on 11/15/2026 14:52

A second positive recommendation from the IDMC to continue the Phase 2b study with AEF0217

Aelis Farma SA published this content on November 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 15, 2026 at 20:52 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]